false
OasisLMS
ar,zh-CN,zh-TW,en,fr,de,hi,it,ja,es,ur
Catalog
Endovascular Therapy for Acute PE: SCAI/SIR Update ...
Current State of Clinical Trails
Current State of Clinical Trails
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The discussion covers several ongoing randomized trials evaluating pulmonary embolism (PE) interventions. These trials, mostly funded by device companies, aim to compare different treatment approaches, such as catheter-based interventions and anticoagulation. Highlights include the HiPytho trial by Boston Scientific focusing on high-risk PE populations, the PE Track led by Akeith Sista, examining long-term cardiopulmonary outcomes, and DORM-PE analyzing thrombectomy versus anticoagulation. Other significant trials like PIRLIS-2, PYTHO3, and PRESERVE address different patient risks and treatments. Outcomes from these could crucially shape future PE management protocols.
Keywords
pulmonary embolism
randomized trials
catheter-based interventions
anticoagulation
cardiopulmonary outcomes
×